baber/WOPTO huggingface dataset:
Patent CY-1111939-T1 (CY)
Title: Φαρμακευτικο στερεο παρασκευασμα που περιλαμβανει βενζαζεπινες και μεθοδος παρασκευης αυτου
Inventor: NAKAGAWA SHINSUKE
IPC: A61K31/55
Filed: 2011-02-14
Abstract: Η υπό συζήτηση εφεύρεση παρέχει ένα νέο φαρμακευτικό στερεό παρασκεύασμα που έχει ανώτερες ιδιότητες αποσάθρωσης και εξαιρετική διαλυτότητα που οδηγεί σε ικανοποιητική απορροφησιμότητα δραστικών συστατικών μέσω της γαστρεντερικής οδού. Το φαρμακευτικό στερεό παρασκεύασμα της παρούσας εφεύρεσης περιλαμβάνει: (α) 7-χλωρο-5-υδροξυ-1-[2-μεθυλ-4-(2-μεθυλβενζοϋλαμινο)βεν-ζοϋλ]-2,3,4,5-τετραϋδρο-1Η-βενζοαζεπίνη ή/και άλας αυτής, (β) υδροξυπροπυλκυτταρίνη που περιέχει υδροξυπροποξύλ ομάδα σε ποσότητα 50 % κατά βάρος ή μεγαλύτερη και (γ) τουλάχιστον ένα μέλος επιλεγόμενο από την ομάδα που αποτελείται από καρμελλόζη, μετά νατρίου καρβοξυμεθύλ άμυλο, crospovidone και υδροξυπροπυλκυτταρίνη χαμηλής υποκατάστασης με μέση διάμετρο σωματιδίου από 30 έως 70 μm και 90% αθροιστική διάμετρο σωματιδίου 100 έως 200 μm.
Patent CY-1112653-T1 (CY)
Title: Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
Inventor: ZIEGLER HANS
IPC: C07D231/22
Filed: 2011-11-22
Abstract: Η παρούσα εφεύρεση αφορά νέες κρυσταλλικές τροποποιήσεις της πυρακλοστροβίνης, μεθόδους για την παρασκευή τους και τη χρησιμοποίηση των νέων τροποποιήσεων για την παρασκευή μέσων φυτοπροστασίας.
Patent CY-1113658-T1 (CY)
Title: Νεα μεθοδος συνθεσης της ιβαβραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
Inventor: PEGLION JEAN-LOUIS
IPC: A61P9/00
Filed: 2012-11-21
Abstract: Μέθοδος παρασκευής της ιβαβραδίνης του τύπου (Ι):
Patent CY-1115048-T1 (CY)
Title: Καθαρισμος 1-[2-(2,4-διμεθυλοφαινυλοσουλφανυλο)φαινυλο]πιπεραζινης
Inventor: NICOLAJSEN HENRIK VIGAN
IPC: C07D295/096
Filed: 2013-12-20
Abstract: Η παρούσα εφεύρεση αφορά σε μια μέθοδο παρασκευής 1-[2-(2,4-διμεθυλοφαινυλοσουλφανυλο)φαινυλο]πιπεραζίνης.
Patent CY-1116260-T1 (CY)
Title: Μεθοδοι παρασκευης παραγωγων κιναζολινονης
Inventor: HANSEN HENRIK C
IPC: C07D239/91
Filed: 2015-05-11
Abstract: Η παρούσα αποκάλυψη σχετίζεται με μεθόδους για παρασκευή ενώσεων, οι οποίες είναι χρήσιμες για την ρύθμιση της έκφρασης της απολιποπρωτεΐνης Α-Ι (ΑpoΑ-Ι) και στην αγωγή και πρόληψη καρδιαγγειακής πάθησης και σχετικών καταστάσεων παθήσεων, συμπεριλαμβάνοντας σχετικές με χοληστερόλη ή λιπίδια διαταραχές, όπως είναι, για παράδειγμα, η αθηροσκλήρυνση.
Patent CY-1118153-T1 (CY)
Title: Αγωγη μικροβιακων μολυνσεων
Inventor: FOSTER TIMOTHY
IPC: A61K38/16
Filed: 2016-10-26
Abstract: Η παρούσα εφεύρεση αφορά βελτιωμένα εμβόλια μικροβιακού αντιγόνου, φαρμακευτικές συνθέσεις, ανοσογονικές συνθέσεις και αντισώματα και τη χρήση αυτών στην αγωγή μικροβιακών μολύνσεων, συγκεκριμένα αυτών βακτηριακής προέλευσης, συμπεριλαμβανομένης Σταφυλοκοκκικής προέλευσης. Κατά ιδανικό τρόπο, η παρούσα εφεύρεση αφορά ένα ανασυνδυασμένο σταφυλοκοκκικό MSCRAMM ή ομοιάζουσες προς MSCRAMM πρωτεΐνες ή θραύσμα αυτών, με μειωμένη δέσμευση προς τον προσδέτη ξενιστή αυτού για χρήση στη θεραπεία.
Patent CY-1120467-T1 (CY)
Title: Διασπειρομενη στο στομα μοναδα δοσης που περιεχει ενα συστατικο οιστετρολης
Inventor: JASPART SÉVERINE FRANCINE ISABELLE
IPC: A61K31/565
Filed: 2018-05-14
Abstract: Η εφεύρεση παρέχει μια διασπειρόμενη στο στόμα στερεά φαρμακευτική μονάδα δόσης που έχει ένα βάρος μεταξύ 30 και 1.000 mg, η οποία εν λόγω μονάδα δόσης αποτελείται από: · 0.1-25 % του βάρους σωματίδια οιστετρόλης που περιέχουν τουλάχιστον 80 % του βάρους ενός συστατικού οιστετρόλης που επιλέγεται από την οιστετρόλη, τους εστέρες οιστετρόλης και τους συνδυασμούς αυτών και · 75-99.9 % του βάρους ενός ή περισσότερων φαρμακευτικά αποδεκτών συστατικών, η στερεά μονάδα δόσης περιλαμβάνει τουλάχιστον 100mg του συστατικού οιστετρόλης και όπου η στερεά μονάδα δόσης μπορεί να ληφθεί με μια διαδικασία που περιλαμβάνει τη συμπίεση ενός ξηρού μίγματος σωματιδίων οιστετρόλης και ενός ή περισσότερων φαρμακευτικά αποδεκτών εκδόχων σε μια στερεά μονάδα δόσης. Η στερεά μονάδα δόσης είναι εύκολο να κατασκευαστεί και είναι κατάλληλη για υπογλωσσική, στοματική ή υπο-χειλική χορήγηση.
Patent CY-1120583-T1 (CY)
Title: Σκευασματα ινσουλινης για γρηγορη προσληψη
Inventor: STEINER SOLOMON S
IPC: A61K47/18
Filed: 2018-07-24
Abstract: Στην παρούσα περιγράφονται ενέσιμα σκευάσματα ινσουλίνης με βελτιωμένη σταθερότητα και ταχεία έναρξη δράσης. Τα σκευάσματα μπορεί να είναι για υποδόρια, ενδοδερμική ή ενδομυϊκή χορήγηση. Στον προτιμώμενο τρόπο υλοποίησης, τα σκευάσματα χορηγούνται μέσω υποδόριας ένεσης. Τα σκευάσματα περιέχουν ινσουλίνη σε συνδυασμό με έναν χηλικοποιητή και παράγοντα διάλυσης και προαιρετικά επιπρόσθετα έκδοχα. Στον προτιμώμενο τρόπο υλοποίησης, το σκεύασμα περιέχει ανθρώπινη ινσουλίνη, έναν χηλικοποιητή ψευδαργύρου όπως το EDTA και έναν παράγοντα διάλυσης όπως το κιτρικό οξύ ή το κιτρικό νάτριο. Αυτά τα σκευάσματα απορροφώνται ταχέως στην κυκλοφορία του αίματος όταν χορηγούνται με υποδόρια ένεση.
Patent CY-1122948-T1 (CY)
Title: 1η-πυρρολο[2,3-c]πυριδιν-7(6η)-ονες και πυραζολο[3,4-c]πυριδιν-7(6η)-ονες ως αναστολεις των βετ πρωτεϊνων
Inventor: COMBS ANDREW P
IPC: C07D471/04
Filed: 2020-04-27
Abstract: Η παρούσα εφεύρεση αφορά σε υποκατεστημένες πυρρολοπυριδινόνες και υποκατεστημένες πυραζολοπυριδινόνες οι οποίες είναι αναστολείς των ΒΕΤ πρωτεϊνών όπως ΒRD2, ΒRD3, ΒRD4 και ΒRD-t και είναι χρήσιμες στη θεραπεία ασθενειών όπως καρκίνου.
Patent CY-1124786-T1 (CY)
Title: Μεθοδος για την υποβρυχια δοκιμη ενος συστηματος διηθησης
Inventor: PEDENAUD PIERRE
IPC: B01D61/12
Filed: 2021-07-13
Abstract: Η εφεύρεση αφορά μια μέθοδο για τη δοκιμή ενός υποβρυχίου συστήματος διήθησης και την υποβρύχια συσκευή δοκιμής που επιτρέπει τη μελέτη της λειτουργίας του συστήματος διήθησης υπό υδατικές συνθήκες. Η μέθοδος δοκιμής περιλαμβάνει βήματα που συνίστανται στην εισαγωγή μιας ροής νερού εντός της υποβρύχιας συσκευή δοκιμής μέσω μίας εισόδου νερού, όπου η εν λόγω υποβρύχια συσκευή δοκιμής περιλαμβάνει τουλάχιστον ένα φίλτρο καθοδήγηση της εν λόγω ροής εντός της υποβρύχιας συσκευή δοκιμής στο εν λόγω φίλτρο, λήψη ενός διηθήματος καθοδικά του εν λόγω φίλτρου και εξαγωγή του εν λόγω διηθήματος στο περιβάλλον μέσω ενός αγωγού εκκένωσης. Η υποβρύχια συσκευή δοκιμής είναι τοποθετημένη τουλάχιστον 500 μέτρα κάτω από την επιφάνεια.
Patent SI-1572167-T1 (SI)
Title: Transdermal buprenorphine dosage regimen for analgesia
Inventor: REIDENBERG BRUCE E
IPC: A61K31/00
Filed: 2003-12-15
Abstract: Dosage regimens of buprenorphine achieving rapid pain relief without increasing nausea, vomiting, or other adverse effects, are described. Also described are buprenorphine dosage regimens for treating chronic pain comprising administering to the patient (1) a first buprenorphine-containing transdermal dosage form for a first dosing period that is no more than about 5 days; (2) a second buprenorphine-containing transdermal dosage form for a second dosing period that is no more than 5 days, the second dosage form comprising the same dosage of buprenorphine as, or a greater dosage of buprenorphine than, the first dosage form; and (3) a third buprenorphine-containing transdermal dosage form for a third dosing period, the third dosage form comprising a greater dosage of buprenorphine than the second dosage form.
Patent TR-200605540-T1 (TR)
Title: Anestezi sırasında hastadan karbondioksit ve karbonmonoksidin tahliyesi.
Inventor: MCNEIRNEY JOHN C
IPC: A61M16/01
Filed: 2005-04-04
Abstract: Anestesi sırasında hastanın soluk verdiği gazlardan karbon dioksid ve karbon monoksidın çıkarılması için moleküler eleklerin uygulanmasına vönelik bir yöntem ve sistem. Sistem özellikle halojene eter mhalasyon anestetik ajanlarından herhangi birinin kullanıldığı anestezide faydalıdır. Soluk verilen gazlar, suyun çıkması için reaktif olmayan bir kurutucu kullanılarak kurutulur, 0,3 mikrondan büyük partikülleri çıkarabilen bir filtreden geçirilir, karbon dioksid ve karbon monoksidi çıkarabilen doğal yada sentetik moleküler elekler içeren bir yataktan geçilir ve daha sonra hastaya geri dönmesi için soluma devresine geri verilir.
Patent DE-3586604-T2 (DE)
Inventor: TAYLOR JOHN EDWARD
IPC: G02B6/44
Filed: 1985-03-13
Granted: 1993-02-25
Abstract: ) An overhead electric conductor comprises a central tubular metal core 52, at least one layer 55 of helically wound bare metal wires surrounding the core and, loosely housed in the bore of the core, at least one optical fibre element 11. The optical fibre element 11 comprises a flexible tube 17 of elongate transverse cross-section in which is loosely housed an optical fibre ribbon structure 12 and which is resiliently set in such a form that it follows a path of smoothly curved undulations, the axes of curvature of which lie parallel to one another and normal to the axis of the tube. Should a tensile force applied to the overhead conductor be transferred to the loosely housed optical fibre element, the flexible tube of the element will tend to straighten in a lengthwise direction against the action of its resilient set thereby to reduce any tensile force that might otherwise be applied to the optical fibres and, when the tensile force is removed, the tube will return under the action of its resilient set towards its original form.
Patent DE-3751580-T2 (DE)
Inventor: WIKSELL HANS
IPC: A61M1/00
Filed: 1987-04-27
Granted: 1996-05-15
Abstract: The present invention relates to an equipment for use in surgical operations to remove tissue, and comprises an ultrasonic knife (101) having a tip intended to be brought into contact with the tissue, a transducer unit (107) causing said tip portion to oscillate longitudinally and a frequency generator (109) to drive the transducer unit (107), the parts of the ultrasonic knife (101) which are in contact with the patient being galvanically isolated from the other equipment of the knife, as well as means for temporarily supplying thermal energy to the tissue from the tip portion of the ultrasonic knife (101) in order to achieve hemostasis by means of coagulation.
Patent DE-3780843-T2 (DE)
Inventor: DUSSOURD D HINTERLAND LUCIEN
IPC: A61K35/74
Filed: 1987-03-16
Granted: 1992-12-24
Abstract: The invention relates to a process for preparing membrane proteoglycans of bacteria selected from: Klebsiella, Serratia and Corynebacterium, starting from a clarified lysate of the said bacterial strain, wherein a) the supernatant of the clarified lysate is treated with cetyltrimethylammonium or trichloroacetic acid, and b) after treatment, the supernatant containing the purified membrane proteoglycans is separated from the precipitated impurities.
Patent DE-3785949-T2 (DE)
Inventor: TAICHER ZVI
IPC: G01V3/32
Filed: 1987-03-10
Granted: 1993-09-09
Abstract: Nuclear magnetic resonance sensing apparatus includes one or more magnets (10) operative to generate a static magnets (10) define a longitudinal axis (8) the static magnetic field in a region (9) remote therefrom containing materials sought to be analyzed. The one or more magnetic field having a static field direction (12) substantially perpendicular to the longitudinal axis and having generally uniform amplitude along the azimuth with respect to the longitudinal axis in the remote region (9). Apparatus (16) generates a radio frequency magnetic field in the remote region (9) for exciting nuclei of the material sought to be analyzed and has a radio frequency magnetic field direction substantially perpendicular to both the longitudinal axis (8) and to the static field direction (12). Apparatus (26) receives nuclear magnetic resonance signals from the excited nuclei and provides an output indication of the properties of the material sought to be analyzed. Methods for nuclear magnetic resonance sensing are also described and claimed.
Patent DE-3786118-T2 (DE)
Inventor: BRU-MAGNIEZ NICOLE
IPC: C07D295/073
Filed: 1987-07-07
Granted: 1993-10-28
Abstract: The present invention relates to novel compounds corresponding to the formula:   <IMAGE>   in which: n represents an integer between 1 and 8 and optimally 2 or 3; (CH2)n-N can also form a ring or a heterocycle, for example having 5 to 7 atoms and preferably 6 atoms; R1 and R2 can represent hydrogen or a lower alkyl having 1 to 5 carbon atoms or can form, together with the nitrogen, a ring such as pyrrolidine, piperidine, morpholine, thiomorpholine, phenyltetrahydropyridine, piperazine or piperazine N-substituted by an alkyl, a phenyl or a heterocycle; in the case of the phenyltetrahydropyridines and the phenylpiperazines or heteroarylpiperazines, the phenyl or the heterocycle may or may not be substituted by halogens or methoxy, thiomethyl, hydroxyl, nitro, amino, cyano, lower alkyl, trifluoromethyl or trichloromethyl groups; and R3, R4 and R5 can represent hydrogen, a lower alkyl, a hydroxyalkyl or hydroxybenzyl group, a halogen, a trifluoromethyl, a methoxy, a thiomethyl or a nitro or two of them can form a ring, in particular a phenyl in the case of the triazoloquinolines or the triazoloisoquinolines; and the non-toxic acid addition salts. These products are useful as drugs and possess analgesic properties, acting especially on the central nervous system as minor tranquilizers.
Patent DE-3874815-T2 (DE)
Inventor: LAAPOTTI JORMA
IPC: D21F3/04
Filed: 1988-06-16
Granted: 1993-02-04
Abstract: Press section of a paper machine, in which the paper web (W) coming from the forming wire (10) of the paper machine is passed through the first two-felt nip (N1). The press section includes a smooth-faced centre roll (40), against which two single-felt nips (N2,N3) are formed. The nip (N2) is placed at a certain distance from the first two-felt nip (N1), whereat the web (W) runs the passage determined by said distance as a straight run supported by the first upper fabric (20). The web (W) departs from the first upper fabric (20) when carried by the smooth (41) face of the centre roll (40) and is shifted on it further into the third nip (N3). The web (W) is detached from the face (41) of the centre roll (40) and passed further. The first nip (N1) is formed between a pick-up suction roll (21 ) placed inside the first upper fabric (20) and a hollow-faced (32) press roll (31). The web (W) is transferred by means of the suction zone (21a) of the pick-up suction roll (21) from the forming wire (10) onto the first fabric (20) and on that fabric further into the first nip (N1). A first lower press fabric (30) is provided around said press-suction roll (31). The web (W) is carried on the lower face of the first upper fabric (20) into the second nip (N2).
Patent DE-3888639-T2 (DE)
Inventor: CLARK BRIAN
IPC: H02G15/04
Filed: 1988-12-01
Granted: 1994-11-03
Abstract: Environmental sealing may be achieved by means of a flexible envelope having therein a sealing material having a cone penetration value preferably from 100-350 (10<-><1> mm) and an ultimate elongation of at least 100%. The material is preferably mechanically deformed preferably by shear and preferably causing it to be comminuted.
Patent TR-199900321-T2 (TR)
Inventor: FEDOULOFF MICHAEL
IPC: C07D498/04
Filed: 1997-08-11
Abstract: SB 207266 veya farmasötik olarak kabul edilebilir bir tuzunun hazirlanmasi için, N-(1-n butil-4-piperidil)metilaminin, R'nin alkil oldugu bir formül (A) bilesimiyle tepkimeye sokulmasini içeren bir proses.
Patent TR-199900831-T2 (TR)
Title: 2-hidroksietil metakrilat ihtiva eden poliolefinler.
Inventor: WANG JAMES HONGXUE
IPC: C08F255/00
Filed: 1997-09-30
Abstract: Polietilen ya da polipropilen gibi bir poliolefin, poliolefin omurgasi üzerine agirlik yüzdesinin 5'inden agirlik yüzdesinin yaklasik 30'una kadar 2-hidroksietil metakrilat asilanarak degistirilir. Asilama için uygun polietilen karisimlarina, ultra yüksek moleküler agirlikli polietilen, yüksek yogunluklu polietilen, ultra düsük yogunluklu polietilen, düsük yogunluklu polietilen, düzlem düsük yogunluklu polietilen ve polipropilen dahildir.
Patent TR-199900860-T2 (TR)
Inventor: ROMEO AURELIO
IPC: A61K9/00
Filed: 1997-10-17
Abstract: Alifatikler ve veya amino gruplari içeren bazik bir anestetik ile hialüronik asitten olusan tuzlari, özellikle de benzidamin ya da büpivaksinli tuzlari kapsayan farmasötik preparatlar tarif edilmistir.
Patent TR-199901732-T2 (TR)
Inventor: MURALIDHARA HARAPOANAHALLI S
IPC: C09B61/00
Filed: 1997-11-24
Abstract: Misir glüteni unundan ksantofilleri geri kazanmak için iyilestirilmis yöntemler saglanmistir. Spesifik olarak, nisbeten kuru misir glüteni ununun, bir organik çözgen ile ekstre edilip, ardindan ksantofil esterlerini ksantofillere dönüstürmek için bir sabunlastirma reaksiyonu yapilan yöntemler tarif edilmistir. Ayrica ksantofilleri geri kazanmak için, nisbeten kuru misir glüteni ununun, bir antioksidan ihtiva eden bir birinci çözgen ile ekstre edilip, bu ekstraktin ihtiyari olarak saflandirildigi yöntemler de tarif edilmistir. Bu yöntemler vasitasiyla ksantofiller, misir glüteni unundan geçmis teknige ait yöntemlere kiyasla daha yüksek verimle, daha yüksek randimanlarla ve daha yüksek saflikla geri kazanilabilirler.
Patent AT-E401069-T2 (AT)
Inventor: MATALON REUBEN
IPC: A61K31/198
Filed: 2004-04-19
Granted: 2008-08-15
Abstract: Disclosed are methods for treating a subject suffering from phenylketonuria and/or phenylalanemia. The methods include, in part, enterally administering to the subject a LNAA supplement in which the weight ration of Leu to Val is greater than 2:1; in which the weight ration of Leu to iLeu is greater than 3:1; or which includes one or more LNAAs and which further includes Lys. LNAA supplements are also disclosed. Also disclosed are methods for treating a subject suffering from a condition involving a metabolic disorder involving the metabolism of a first amino acid X. The method includes enterally administering to the subject a composition which (i) is substantially free from the first amino acid X and (ii) which includes a second amino acid Y that competes with amino acid X at a gastrointestinal tract transporter.
Patent DE-60006838-T2 (DE)
Inventor: DOSMO RENATO
IPC: H02B11/12
Filed: 2000-10-04
Granted: 2004-09-02
Abstract: A connection device for a low-voltage power circuit breaker, wherein the circuit breaker comprises: a fixed part, provided with terminals for connection to an electric circuit in which the circuit breaker is inserted, and with disconnection contacts; a movable part, which can be coupled to the fixed part and comprises an auxiliary module which has contact means, and an interruption block which contains at least one fixed contact and a moving contact which can be mutually coupled and are electrically connected to the contact means; its particularity consists of the fact that is comprises a first conducting element which is suitable to be connected to a corresponding disconnection contact and a second conducting element which is suitable to be connected, respectively, to the first conducting element and to the contact means.
Patent DE-60010574-T2 (DE)
Inventor: RIPART ALAIN
IPC: A61N1/368
Filed: 2000-06-07
Granted: 2005-05-19
Abstract: The multiple electrode cardiac pacemaker system increases the maximum stimulation frequency (Fmax) at regular time intervals during patient convalescence from a starting value (F0) to a final value (F1). The atrioventricular stimulation delay is controlled to suit the stimulation frequency.
Patent DE-60012034-T2 (DE)
Inventor: BAARMAN DAVID W
IPC: F03B17/06
Filed: 2000-10-05
Granted: 2005-07-14
Abstract: A hydro-power generation system for use in conjunction with a water treatment system is disclosed. The embodiments of the hydro-power generation system include an impeller rotatably positioned in a housing. The impeller is rotatably coupled with a generator. When water flows through the water treatment system, water flows to the hydro-power generation system and acts on the impeller causing rotation thereof. The rotation of the impeller results in the generation of electricity for the water treatment system by the generator. Other embodiments of the hydro-power generation system include a rotor rotatably positioned in a conduit through which water flows. The flowing water causes the rotor to rotate. The rotor operatively cooperates with a surrounding stator. As the rotor rotates within the stator electricity is generated for the water treatment system.
Patent DE-60015803-T2 (DE)
Inventor: ERNST TIBOR
IPC: B65F1/16
Filed: 2000-12-21
Granted: 2005-11-03
Abstract: A lid 14 for fitting to an open-topped refuse container 10 has a compacting mechanism mounted on the lid and an opening 90 having a pivoted closure flap 92 to allow waste to be placed in the container without opening the lid. The compacting mechanism comprises a compacting plate 36 mounted under the lid and an actuating rod 38 coupled to the plate whereby the rod may be actuated to move the plate from a storage position wherein the plate is drawn up under the lid to an operative position wherein the plate is pushed downwardly into the container. The compacting plate is pivotable on an end of the actuating rod and the lid and plate are adapted to cooperate to tilt the plate from a horizontal position as it is drawn up into its storage position so that the flap can be opened without obstruction by the plate. <IMAGE>
Patent DE-60020096-T2 (DE)
Inventor: MAGGENTI MARK
IPC: H04W84/08
Filed: 2000-03-24
Granted: 2006-03-09
Abstract: A method and apparatus for providing fair access to members of a group communication system in which the members experience differing signaling delays. Members of the communication system send a transmission request to an arbitration device when they wish to communicate with other members. The transmission requests are ultimately received by the arbitration device. A time window is opened by a processor located at the arbitration device at the time an initial transmission request is received. The time window is used to treat all transmission requests that are received within the time window as having been received at the same time. Any transmission requests that are received within the time window are included in determining which member should be granted an exclusive transmission privilege.
Patent DE-60022898-T2 (DE)
Inventor: HERNANDEZ E
IPC: C07D295/088
Filed: 2000-07-19
Granted: 2006-07-06
Abstract: A process is disclosed for the preparation of a piperazine-substituted aliphatic carboxylate having the formulawhere m and n are individually an integer of from 1 to 6, R and R' are the same or different and are hydrogen, C1 to C6 alkyl or aryl or heteroaryl that is unsubstituted or is substituted with at least one substituent that is halo, C1 to C6 alkyl or C1 to C6 alkoxy and R'' is C3 to C12 branched alkyl or an organic or inorganic cation. The process comprises treating a solution comprising a compound of the formulawherein m, R and R' are as defined above and an aliphatic ester of the formulawhere X is a leaving group and n and R'' are as defined above, with a base in the presence of an effective amount of a phase transfer catalyst, for a time and at a temperature sufficient to form a piperazine-substituted aliphatic carboxylate. Hydrolysis of the carboxylate with acid produces a piperazine-substituted aliphatic carboxylic acid or the acid salt thereof.
Patent DE-60038250-T2 (DE)
Inventor: SNEH OFER
IPC: C23C16/44
Filed: 2000-11-21
Granted: 2008-06-19
Abstract: A new method and apparatus for avoiding contamination of films deposited in layered depositions, such as Atomic Layer Deposition (ALD) and other sequential chemical vapor deposition (CVD) processes, is taught, wherein CVD-deposited contamination of ALD films is prevented by use of a pre-reaction chamber that effectively causes otherwise-contaminating gaseous constituents to deposit on wall elements of gas-delivery apparatus prior to entering the ALD chamber.
Patent DE-60100506-T2 (DE)
Inventor: SCHOENTJES BRUNO
IPC: A61P19/02
Filed: 2001-01-24
Granted: 2004-05-13
Abstract: The invention relates to compounds of formula:and their solvates and/or hydrates exhibiting affinity for the arginine-vasopressin V1b receptors or for both V1b and V1a receptors.The invention also relates to their process of preparation, to the intermediate compounds of formula (II) of use for their preparation, to the pharmaceutical compositions comprising them and to their use for the preparation of medicaments.